PathGen Diagnostik Teknologi is the recently established in early 2020 as a spin-off company of NICCRAT (Nottingham-Indonesia Collaboration for Clinical Research and Training), an academics collaboration initiated by Prof. Mohammad Ilyas (University of Nottingham, UK) and Susanti foster a portfolio of research and training activities with counterparts in Indonesia. PathGen Diagnostik Teknologi focused on the development of low-cost robust molecular diagnostic tools and capacity building to deliver the technologies. The company is located and incubated to Center of innovation at Indonesia Institute of Sciences (Lembaga Pengetahuan Indonesia/LIPI), an Indonesian government research body.